Stock A001360 SAMSUNG PHARM. CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications SAMSUNG PHARM. Co., LTD.

Equities

A001360

KR7001360007

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
1,693 KRW +0.12% Intraday chart for SAMSUNG PHARM. Co., LTD. -0.41% -22.16%
2023 NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI
2023 NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. A001360 Stock
  4. News SAMSUNG PHARM. Co., LTD.
  5. Official Publications
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW